DeVries James T, White Christopher J, Collins Tyrone J, Jenkins J Stephen, Reilly John P, Grise Mark A, McMullan Paul W, Badawi Ramy A, Ramee Stephen R
Department of Cardiovascular Diseases, The Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA.
Catheter Cardiovasc Interv. 2009 Apr 1;73(5):692-8. doi: 10.1002/ccd.21927.
To report the technical success and clinical outcomes of catheter-based therapy (CBT) for acute ischemic stroke in patients ineligible for intravenous thrombolysis.
Acute ischemic stroke is common but undertreated. CBT for acute ischemic stroke is a therapeutic option in selected patients who are not candidates for intravenous thrombolysis.
Consecutive stroke patients who were ineligible for intravenous thrombolysis and underwent CBT were identified by retrospective chart review. Demographic information, National Institutes of Health Stroke Scale (NIHSS), procedural characteristics, and clinical outcomes during hospitalization and at 90 days follow up were collected. Experienced interventional cardiologists with the consultative support of stroke neurologists were on call for acute strokes.
A total of 33 acute ischemic stroke patients underwent emergency cerebral angiography, with 26 patients undergoing CBT. Successful "culprit" artery recanalization was achieved in 23 (88%) of the 26 patients. In-hospital adverse events occurred in 4 (15%) patients, with intracerebral hemorrhage (ICH) (12%) representing the most common adverse event. The baseline NIHSS for patients who underwent intervention was 16.5 +/- 9.9 (median 16) and improved significantly to 9.9 +/- 8.7 (median 9) (P < 0.001) at hospital discharge. A modified Rankin score of two or less (indicating mild disability) was achieved in half (n = 13) of the CBT treated patients. All cause mortality at 90 days was 8% (2/26).
In selected patients, CBT provided by qualified interventional cardiologists supported by stroke neurologists, offers a safe and effective option for patients with acute stroke who are not eligible for intravenous thrombolysis.
报告对不符合静脉溶栓条件的急性缺血性卒中患者进行导管介入治疗(CBT)的技术成功率和临床结果。
急性缺血性卒中很常见,但治疗不足。对于不符合静脉溶栓条件的特定患者,CBT是一种治疗选择。
通过回顾性图表审查确定不符合静脉溶栓条件并接受CBT的连续卒中患者。收集人口统计学信息、美国国立卫生研究院卒中量表(NIHSS)、手术特征以及住院期间和90天随访时的临床结果。经验丰富的介入心脏病专家在卒中神经科医生的咨询支持下随时待命处理急性卒中。
共有33例急性缺血性卒中患者接受了急诊脑血管造影,其中26例患者接受了CBT。26例患者中有23例(88%)成功实现了“责任”动脉再通。4例(15%)患者发生了院内不良事件,其中脑出血(ICH)(12%)是最常见的不良事件。接受干预的患者基线NIHSS为16.5±9.9(中位数16),出院时显著改善至9.9±8.7(中位数9)(P<0.001)。接受CBT治疗的患者中有一半(n = 13)的改良Rankin评分达到2分或更低(表明轻度残疾)。90天时的全因死亡率为8%(2/26)。
在特定患者中,由卒中神经科医生支持的合格介入心脏病专家提供的CBT,为不符合静脉溶栓条件的急性卒中患者提供了一种安全有效的选择。